Literature DB >> 15896831

Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva.

Jesus Gonzalez Bosquet1, Javier F Magrina, Thomas A Gaffey, Jose L Hernandez, Maurice J Webb, William A Cliby, Karl C Podratz.   

Abstract

OBJECTIVES: To assess time to failure and sites of failure with extended follow-up of patients with squamous cell carcinoma (SCC) of the vulva.
METHODS: A retrospective analysis of 330 patients with primary SCC of the vulva treated at Mayo Clinic between 1955 and 1990 was conducted. The main outcome measures were the rates of treatment failure. The Kaplan-Meier method and the log-rank test were used to estimate the rates of overall survival, disease-free survival, and recurrence. The Cox proportional hazards model was used to assess independent variables as prognostic factors for treatment failure.
RESULTS: All 330 patients in the cohort underwent lymphadenectomy; 113 patients (34.2%) had involvement of the inguinofemoral nodes and 88 patients (26.7%) had treatment failure. Treatment failures occurred more frequently in patients who presented with inguinal metastasis at the primary surgery and during the first 2 years of follow-up. After 2 years, both groups, with or without positive inguinal nodes, had similar treatment failure rates. Most patients with disease recurrence in the groin died within the first 2 years of follow-up. Involvement of the inguinal nodes was the main independent predictive factor for survival, disease recurrence, and metastasis.
CONCLUSIONS: Most treatment failures occurred during the 2 years after initial surgical management. However, in 35% of patients, disease reoccurred 5 years or more after diagnosis, which demonstrates the need for long-term follow-up. Complete ipsilateral or bilateral inguinofemoral lymph node dissection ensures a thorough evaluation and treatment of the groin.

Entities:  

Mesh:

Year:  2005        PMID: 15896831     DOI: 10.1016/j.ygyno.2005.03.006

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

1.  Cost-effectiveness analysis of sentinel lymph node biopsy in the treatment of early-stage vulvar cancer.

Authors:  Britt K Erickson; Laura M Divine; Charles A Leath; J Michael Straughn
Journal:  Int J Gynecol Cancer       Date:  2014-10       Impact factor: 3.437

2.  Reconstruction of acquired perineovulvar defects: a proposal of sequence.

Authors:  J Joris Hage; Marc van Beurden
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

3.  [Lymphadenectomy of the inguinal region and pelvis].

Authors:  P M Vogt; L-W Lahoda; M Meyer-Marcotty; M Spies; K H Busch
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

4.  Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration.

Authors:  Katharina Röhrmoser; Atanas Ignatov; Michael Gerken; Olaf Ortmann; Monika Klinkhammer-Schalke; Thomas Papathemelis
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-18       Impact factor: 4.553

5.  Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer.

Authors:  Sylwia Kellas-Ślęczka; Brygida Białas; Marek Fijałkowski; Piotr Wojcieszek; Marta Szlag; Agnieszka Cholewka; Maciej Ślęczka; Zofia Kołosza
Journal:  J Contemp Brachytherapy       Date:  2016-02-29

Review 6.  Surveillance and Care of the Gynecologic Cancer Survivor.

Authors:  Stephanie S Faubion; Kathy L MacLaughlin; Margaret E Long; Sandhya Pruthi; Petra M Casey
Journal:  J Womens Health (Larchmt)       Date:  2015-07-24       Impact factor: 2.681

7.  Surgical management for squamous cell carcinoma of vulva.

Authors:  Ayi Kossigan Amavi; Laurent Kouadio; Komlan Adabra; Kodjo Tengue; Fouad Tijami; Abdelouahed Jalil
Journal:  Pan Afr Med J       Date:  2016-06-15

8.  Bilateral Breast Metastases from Vulvar Carcinoma: A Case Report and Literature Review.

Authors:  D C Papatheodorou; C G Liakou; K Kalogerakos; Johannes Carl Athanasios Dimopoulos; N Kalinoglou
Journal:  Case Rep Obstet Gynecol       Date:  2017-04-12

Review 9.  Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement.

Authors:  Alpaslan Kaban; Işık Kaban; Selim Afşar
Journal:  Gynecol Oncol Rep       Date:  2017-02-10

10.  Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Authors:  Toshiaki Saito; Tsutomu Tabata; Hitoshi Ikushima; Hiroyuki Yanai; Hironori Tashiro; Hitoshi Niikura; Takeo Minaguchi; Toshinari Muramatsu; Tsukasa Baba; Wataru Yamagami; Kazuya Ariyoshi; Kimio Ushijima; Mikio Mikami; Satoru Nagase; Masanori Kaneuchi; Nobuo Yaegashi; Yasuhiro Udagawa; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2017-11-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.